Status:
UNKNOWN
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
Third Affiliated Hospital, Sun Yat-Sen University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the efficacy of autologous bone marrow mesenchymal stem cells (MSCs) transplantation via hepatic artery in the treatment of liver cirrhosis. Liver function ...
Detailed Description
Patients with liver cirrhosis were randomly separated into two groups. Autologous MSCs were infused to patients using interventional method via hepatic artery for One group. The catheter was inserted ...
Eligibility Criteria
Inclusion
- Age 18-70 years.
- Imaging evidences of liver cirrhosis.
- Child-Plough score of 10 or more.
Exclusion
- Liver tumor on ultrasonography, CT or MRI examination.
- Problems in organs other than the liver(e.g.the heart or lungs).
- History of moderate to severe hepatic encephalopathy or variceal bleeding.
- Imaging evidences of vascular thromboses.
- Coma.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00976287
Start Date
January 1 2008
End Date
June 1 2010
Last Update
September 15 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.